RJFSA
HELP

Raymond James Financial Services Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Raymond James Financial Services Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,411
Closed -$24.8K – 3466
2024
Q2 		$24.8K Sell
2,411
-131
-5% -$1.72K ﹤0.01% 3337
2024
Q1 		$39.9K Buy
+2,542
New +$36.7K ﹤0.01% 3313
2023
Q2 		– Sell
-345
Closed -$5.04K – 3262
2023
Q1 		$5.04K Buy
345
+66
+24% +$1.07K ﹤0.01% 3243
2022
Q4 		$3.15K Sell
279
-13
-4% -$214 ﹤0.01% 3230
2022
Q3 		$5K Buy
+292
New +$7.91K ﹤0.01% 3230

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Raymond James Financial Services Advisors's HELP Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 2,411 shares — an estimated $24.8K sold.

Raymond James Financial Services Advisors first reported a position in HELP in Q3 2022 and held it in 5 quarters. The position peaked at $39.9K in Q1 2024. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Raymond James Financial Services Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 2,411 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $24.8K.
  • Raymond James Financial Services Advisors first reported a position in Helus Pharma Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Raymond James Financial Services Advisors's Helus Pharma Inc. Common Stock position peaked at $39.9K in Q1 2024.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.